What is Lassiter Drug?
Lassiter Drug specializes in the meticulous compounding of personalized medications tailored for both human and animal patients, addressing unique physician and patient requirements. Beyond its core compounding services, the company offers convenient vaccinations for Influenza and Pneumonia, administered by its team of trained pharmacists. The organization cultivates a strong emphasis on customer care, fostering a family-like atmosphere that has positioned it as a preferred provider. Its association with the OK Wellness Center further highlights a commitment to proactive health management, focusing on mitigating risks associated with heart disease and diabetes.
How much funding has Lassiter Drug raised?
Lassiter Drug has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Lassiter Drug
PPP
Public-Private Partnership
What's next for Lassiter Drug?
The substantial large-scale late-stage funding indicates Lassiter Drug is poised for significant expansion and strategic development. This capital infusion is likely to fuel advancements in its personalized medication compounding technologies, potentially broadening its service offerings and market reach. Further investment may also be directed towards enhancing operational efficiencies, expanding its pharmacy network, and strengthening its partnerships, including those with the OK Wellness Center, to further its mission of comprehensive patient care and disease risk reduction.
See full Lassiter Drug company page
